The Medical Marijuana Information Resource Centre is established to provide patients, caregivers, and clinicians with a source of scientific and current information about the use of marijuana (cannabis) as a medicine.

-
March 22, 2007
Cannabinoid market forecast at over $700 million
Pharma Marketletter
- With four drugs now in the marketplace (a 100% rise from two years ago), the cannabinoid market continues to grow, says a new report from Visiongain, which values the market for such drugs at $709.5 million at present, up from $386.7 million in 2006.
-
March 1, 2007
Marijuana as wonder drug
The Boston Globe
- A new study in the journal Neurology is being hailed as unassailable proof that marijuana is a valuable medicine. It is a sad commentary on the state of modern medicine - and US drug policy - that we still need "proof" of something that medicine has known for 5,000 years.
-
February 15, 2007
GW Partners Sativex With Otsuka In Potential $273M Deal
BIOWORLD Today
- GW Pharmaceuticals plc handed over development and U.S. marketing rights to its cannabinoid cancer pain compound to Otsuka Pharmaceutical Co. Ltd. in a deal that brings GW $18 million up front, along with milestone payments that could add $255 million.